SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-052659
Filing Date
2020-10-01
Accepted
2020-10-01 17:00:57
Documents
2
Period of Report
2020-09-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1533
2 POA DOCUMENT poa.txt EX-24.3_939296 2076
  Complete submission text file 0001209191-20-052659.txt   5035
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130
Business Address
GAROFALO ELIZABETH A. (Reporting) CIK: 0001826361 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50768 | Film No.: 201216908